chevron_leftBack
As of 5 June 2026, SymBio Pharmaceuticals Ltd. has a market cap of $41.27M USD, ranking #31944 globally and #3004 in Japan.
It ranks #2884 in the Healthcare sector, and #1002 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$41.27MUSD
6.6B JPY
Enterprise Value
$35.63MUSD
5.7B JPY
Revenue (TTM)
$8.17MUSD
1.31B JPY
Net Income (TTM)
-$29.85MUSD
-4.78B JPY
PS Ratio
5.1
PB Ratio
5.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Fuminori Yoshida
open_in_new
Employees
91
Founded
2005
Website
symbiopharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -5.2% | -23% | 3.4% | -25% | -41% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4582
シンバイオ製薬株式会社
ISIN: JP3383050006
Shares Out.:
Shares Outstanding:
76.261M1
Shares Float:
72.903M2
|
92 JPY | |
|
SYMQY
シンバイオ製薬株式会社 ADR
ISIN: US87150Y1001
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.5579 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About SymBio Pharmaceuticals Ltd.
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSE: 4519
|
$81.66B
198K%
13.07T JPY
|
28.9
|
|
TSE: 4502
|
$52.21B
126K%
8.36T JPY
|
75.1
|
|
TSE: 4578
|
$36.84B
89K%
5.9T JPY
|
15.7
|
|
TSE: 4568
|
$30.37B
74K%
4.86T JPY
|
16.2
|
|
TSE: 4503
|
$25.82B
62K%
4.13T JPY
|
14.2
|
|
TSE: 4507
|
$16.91B
41K%
2.71T JPY
|
13.9
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
1M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
874K%
|
97.4
|
|
SIX: RO
|
$324.68B
787K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
701K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
672K%
218.9B CHF
|
20.5
|
chevron_leftBack